Sign inJoin waitlistJoin the waitlist

Jenna Rossoff

Program Director · McGaw Medical Center of Northwestern University

Credentials: · · · ·

History

McGaw Medical Center of Northwestern University
Present
McGaw Medical Center of Northwestern University
Present

Pediatric Hematology/Oncology
McGaw Medical Center of Northwestern University
2016–2019
Pediatrics
McGaw Medical Center of Northwestern University
2013–2016
Rutgers, Robert Wood Johnson Medical School
2009–2013

Research

Disease Burden Affects Outcomes in Pediatric and Young Adult B-Cell Lymphoblastic Leukemia After Commercial Tisagenlecleucel: A Pediatric Real-World Chimeric Antigen Receptor…
Journal of Clinical Oncology · 2022 · 212 citations
Pediatric Acute Lymphoblastic Leukemia, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2020 · 153 citations
Noninvasive Diagnosis of Infection Using Plasma Next-Generation Sequencing: A Single-Center Experience
Open Forum Infectious Diseases · 2019 · First of 7 authors · 109 citations

Liora Schultz
16 papers
TB
Tina Baggott
16 papers
Amy Moskop
15 papers · 5 as a fellow
KC
Kevin Curran
15 papers
NK
Nicole Karras
15 papers
Prakash Satwani
15 papers
Theodore Laetsch
15 papers
Vanessa Fabrizio
15 papers · 5 as a fellow
Gary Myers
14 papers
HP
Holly Pacenta
14 papers
Michael Verneris
14 papers
Michelle Hermiston
14 papers

Clinical trials

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
Site PI · Recruiting · Phase 1
Therapeutic Advances in Childhood Leukemia Consortium
2022–2027
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Site PI · Recruiting · Phase 1, Phase 2
PedAL BCU, LLC
2022–2030
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
Site PI · Recruiting · Phase 2
Etan Orgel
2022–2032
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2020–2028